These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 98773)

  • 1. [The preparation of nitroglyerin tablets with protracted action].
    Krówczynski L; Stozek T; Rogacka K
    Pharmazie; 1978 Jun; 33(6):354-6. PubMed ID: 98773
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of an oral nitroglycerin proxyphyllin retard compound].
    Ritschel WA; Clotten R
    Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053
    [No Abstract]   [Full Text] [Related]  

  • 3. [Injection-molding technic for the production of oral delayed-action preparations. 3. Addition of highly water-soluble substances].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1975 Aug; 30(8):536-40. PubMed ID: 1178778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tabletting of a nitroglyceryl inclusion compound and testing of sustained release tablets].
    Kata M; Wayer M; Szabóné Révész P; Kedvessy G; Stadler-Szöke A; Szejtli J
    Acta Pharm Hung; 1986 Jul; 56(4):157-63. PubMed ID: 3092569
    [No Abstract]   [Full Text] [Related]  

  • 5. [Angina pectoris treated with delayed-action nitroglycerin. A double-blind study].
    Hvidt S
    Ugeskr Laeger; 1968 Nov; 130(47):2010-2. PubMed ID: 4975078
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L; Naplatanova D
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of formulating factors on drug safety of timed-release nitroglycerin tablets.
    Ritschel WA
    J Pharm Sci; 1971 Nov; 60(11):1683-5. PubMed ID: 5002527
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
    Mank R; Kala H; Richter M; Babel W; Sattler K
    Pharmazie; 1989 Aug; 44(8):545-7. PubMed ID: 2594825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Injection die-casting procedure in the preparation of oral delayed-action preparations. 7. Curing with energy-rich radiation].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1977 Jan; 32(1):30-3. PubMed ID: 840875
    [No Abstract]   [Full Text] [Related]  

  • 10. Mathematical relationship of in vitro release rates and biological availability of controlled-release nitroglycerin (nitrong).
    Ipsen J
    Curr Ther Res Clin Exp; 1971 Mar; 13(3):193-208. PubMed ID: 4998572
    [No Abstract]   [Full Text] [Related]  

  • 11. Automated analysis of nitroglycerin in tablets.
    Waaler T; Gundersen H; Kvaleid I; Shangraw R
    Pharm Acta Helv; 1977; 52(1-2):17-9. PubMed ID: 407581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of the effect of trinitrolong slabs and nitroglycerin tablets in patients with exertional angina pectoris].
    Martsevich SIu; Metelitsa VI
    Ter Arkh; 1981; 53(4):16-8. PubMed ID: 6789489
    [No Abstract]   [Full Text] [Related]  

  • 13. Formula optimization based on neural networksin sustained release tablets.
    Wei X; Liang W
    Pharmazie; 2003 Jul; 58(7):521-2. PubMed ID: 12889541
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the accuracy of different types of dissolution rate methods.
    Bolhuis GK; Lerk CF; Zuurman K
    Pharm Weekbl; 1973 Jan; 108(3):49-53. PubMed ID: 4699088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in the production and control of tablets. XVI. Various types of oral preparations with delayed action].
    Chalabala M; Vitková M
    Cesk Farm; 1976 Mar; 25(2):79-81. PubMed ID: 1277318
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preparation of delayed action micropills of oxytetracycline and their in vitro study].
    Pandula E; Tarjányi S; Csontos A; Nagy I
    Acta Pharm Hung; 1968 Nov; 38(6):400-4. PubMed ID: 5706380
    [No Abstract]   [Full Text] [Related]  

  • 17. [Attempt to improve stability of nitroglycerin in tablets].
    Stozek T; Rogacka-Majcher K
    Folia Med Cracov; 1979; 21(1):173-8. PubMed ID: 120293
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of some factors affecting the in-vitro release of drug from prolonged release granulations. 1. Effect of method of preparation.
    Asker AF; Motawi AM; Abdel-Khalek MM
    Pharmazie; 1971 Mar; 26(3):170-2. PubMed ID: 5574493
    [No Abstract]   [Full Text] [Related]  

  • 19. Long acting methadone formulation. Part 3: Preparation and in vivo evaluation of tablets containing methadone salts and methadone-naloxone combinations.
    Choulis NH; Abellana-Intaphan L
    Pharmazie; 1977; 32(8-9):518-9. PubMed ID: 594119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.